Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
AZD0022
AZD0022 | KRAS G12D inhibitor | Probechem Biochemicals
AZD0022 | KRas inhibitor | CAS 2958627-18-2 | Selleck
Structure of AZD3582. | Download Scientific Diagram
AZD0022 | Orally available KRAS G12D inhibitor | Antitumor | TargetMol
AZD0022 Explained: How AstraZeneca’s New Drug Could Transform Cancer ...
Study on the Safety and Effectiveness of AZD0022 Alone and with Other ...
AZD0022 | 可口服和选择性的KRAS G12D抑制剂 | 抗肿瘤 | TargetMol
Discovery of Novel Noncovalent KRAS G12D Inhibitors through Structure ...
AZD9574 selectively inhibits and traps PARP1. A, Chemical structure of ...
GZD2202 is a novel Trk inhibitor. (a) Structure of GZD2202. (b) Kinase ...
The structure of AZD2738. | Download Scientific Diagram
AZD0022 是一种选择性具有口服活性的 KRASG12D 抑制剂 | MedChemExpress
Chemical structure of AZD | Download Scientific Diagram
2 The chemical structure of radiolabelled AZD1152-HQPA. | Download ...
Chemical structure of tirzepatide (Mounjaro TM ). Blue: Aminoisobutyric ...
A New Zn(II) Azido Complex of L-Arginine: X-ray Crystal Structure ...
New Bioprecursor Prodrugs of Sulfadiazine: Synthesis, X-ray Structure ...
Crystal structure of (1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N″,N ...
Structure of AZD2563. | Download Scientific Diagram
Ras | Inhibitors | MedChemExpress
TiPLab - 2025AACR年会揭晓的12种新型抗癌药物之：下一代精准KRAS小分子抑制剂
Multiple Strategies to Develop Small Molecular KRAS Directly Bound ...
快讯｜2025年AACR年会上，首次披露值得关注的活性分子！ - 知乎
AZD2389
Structure-Based Design and Synthesis of Potent and Selective KRAS G12D ...
Emerging ADC Targets: B7-H3 and B7-H4
Schematic representation of the AZD2 molecular structure. | Download ...
AZD-5462 | Selleck Chemicals
AZD-0022 - Chemietek
#medicine #aacr25 #pharmaceuticals #healthcare | Chris De Savi | 13 ...
Identification of New KRAS G12D Inhibitors through Computer-Aided Drug ...
KRAS G12C inhibitor 42 | Anti-cancer Agent | MedChemExpress
阿斯利康KRAS G12D抑制剂AZD0022在中国申报临床，拟开发治疗实体瘤
The SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates ...
Xanthosine-5'-monophosphate | TargetMol
Abstract ND11: AZD0022: a potent, oral KRASG12D-selective inhibitor ...
阿斯利康 5 款 1 类新药首次在中国获批临床
一文读懂 KRAS- MedChemExpress - 知乎
KRAS G12D Inhibitor Molecule Overview | Lilly Oncology
CIMB | Free Full-Text | Identification of Dietary Bioflavonoids as ...
【AZD0022】大腸がん、膵がん、非小細胞肺がん / 第I相試験 / KRASG12D阻害剤 | 国立がん研究センター中央病院 先端医療科 ...
Wafik S. El-Deiry: Dr. Susan Galbraith speaks about AstraZeneca ...
A Phase I/IIa Study to Investigate the Safety, Tolerability ...
Characterizations of Nap‐AZD‐Yp before and after enzyme treatments. a ...
科学网—2025 AACR 大会：星光闪耀下的明星分子与关键分子砌块揭秘 | 乐研试剂 - 陈谦的博文
Frontiers | Current status of KRAS G12C inhibitors in NSCLC and the ...
Bringing KRAS G12C Inhibitors to Market: The Game Is On
Frontiers | Discovery of potent and noncovalent KRASG12D inhibitors ...
GSK-A | TargetMol
Discussing AstraZeneca's Brain-penetrating KRAS Inhibitor
ISSX 2022 - Hypha Discovery
2025 美国癌症研究协会年会：12 种创新肿瘤药物亮相
HRS-4642 | KRAS G12D inhibitor | Probechem Biochemicals
KRASG12D inhibition in pancreatic cancer: Fas expression facilitates ...
Vivek Subbiah: Wow! BridgeBio discloses BBO-8520 = inhibitor of on ...
AZD-PEG2-PFP | Biochemical Assay Reagent | MedChemExpress
Binding modes of the KRAS(G12C) inhibitors GDC-6036 and LY3537982 ...
AZD-1305 | Antiarrhythmic Agent | MedChemExpress
KRAS G12D inhibitor 12 | Anti-cancer Agent | MedChemExpress
Frontiers | Transition-metal-catalyzed synthesis of quinazolines: A review
KRAS G12D inhibitor 17 | TargetMol
AZD1656 | Carbohydrate Metabolism activator | CAS 919783-22-5 | Selleck
Clinical PARP inhibitors allosterically induce PARP2 retention on DNA ...
KRAS G12D: The Next Frontier in Cancer Therapy | MedChemExpress
How does AstraZeneca's PARP inhibitor differentiate?
百亿美元市场！领路者阿斯利康两手抓：奥拉帕利再获新适应症，下一代产品多款布局
AZD-1236 | MMP inhibitor | MedChemExpress
KRAS G12D inhibitor 22 | KRAS G12D Inhibitor | MedChemExpress
Drug Hunter - drug discovery, distilled
Pre-clinical Formulation Development of an in situ Meglumine Salt of ...
2025 AACR 大会：明星分子与关键分子砌块揭秘｜乐研试剂
AZD-0156 | CAS 1821428-35-6 | SCBT - Santa Cruz Biotechnology
Tutorial on Describing, Classifying, and Visualizing Common Crystal ...
AZD2389 | Immunology & Inflammation related inhibitor | CAS 2791472-12 ...
祐森健恒许可给阿斯利康的KRAS G12D抑制剂在中国获批临床医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
AZD 6703 | p38 MAPK Inhibitor | MedChemExpress
AZD-9819 | Neutrophil Elastase Inhibitor | MedChemExpress
AZD 9272 (Standard) | mGluR Inhibitor | MedChemExpress
One of the first drugs to be approved for use in the treatment of ...
RCSB PDB - 8R7X: Kras G12D in complex with compound 4
JP-2-249 | TargetMol
CAS 2648552-32-1 (KRAS G12D inhibitor 6) - BOC Sciences
2-(Acetylamino)-2-deoxy-3-O-α-D-galactopyranosyl-D-galactose_TargetMol
AZD8421 | CDK inhibitor | CAS 3047321-53-6 | Selleck
AZD-2327 | δ-Opioid Receptor Agonist | MedChemExpress
Two 1D Chain Structures Derived from Alkaline-Earth Metal Complexes and ...
AZD-2207 | CB1 Antagonist | MedChemExpress
RMC-9805 | Zoldonrasib | KRAS G12D Inhibitor | TargetMol
Structural Identification and Synthesis of the Acyl Glucuronide of ...
Azure Developer CLI templates | Microsoft Learn
Design, Synthesis, Anticancer Evaluation and Molecular Docking of ...
